Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Chem ; 15(2): 213-221, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36302868

ABSTRACT

Molecular photoelectrochemical devices are hampered by electron-hole recombination after photoinduced electron transfer, causing losses in power conversion efficiency. Inspired by natural photosynthesis, we demonstrate the use of supramolecular machinery as a strategy to inhibit recombination through an organization of molecular components that enables unbinding of the final electron acceptor upon reduction. We show that preorganization of a macrocyclic electron acceptor to a dye yields a pseudorotaxane that undergoes a fast (completed within ~50 ps) 'ring-launching' event upon electron transfer from the dye to the macrocycle, releasing the anionic macrocycle and thus reducing charge recombination. Implementing this system into p-type dye-sensitized solar cells yielded a 16-fold and 5-fold increase in power conversion efficiency compared to devices based on the two control dyes that are unable to facilitate pseudorotaxane formation. The active repulsion of the anionic macrocycle with concomitant reformation of a neutral pseudorotaxane complex circumvents recombination at both the semiconductor-electrolyte and semiconductor-dye interfaces, enabling a threefold enhancement in hole lifetime.

2.
J Neuroimmunol ; 278: 271-6, 2015 Jan 15.
Article in English | MEDLINE | ID: mdl-25468776

ABSTRACT

Inflammation plays a key role in the pathophysiology of Glioblastoma Multiforme (GBM). Here we focus on the contribution of the so far largely ignored complement system. ELISA and immunohistochemistry were combined to assess levels and localization of critical components of the initiation- and effector pathways of the complement cascade in sera and tumor tissue from GBM patients and matched controls. Serum levels of factor-B were decreased in GBM patients whereas C1q levels were increased. C1q and factor-B deposited in the tumor tissue. Deposition of C3 and C5b-9 suggests local complement activation.MBL deficiency, based on serum levels, was significantly less frequent among GBM patients compared to controls (14% vs. 33%). Therefore low levels of MBL may protect against the initiation/progression of GBM.


Subject(s)
Brain Neoplasms , Complement Activation , Glioblastoma , Adult , Brain Neoplasms/blood , Brain Neoplasms/immunology , Brain Neoplasms/physiopathology , Complement C1q/metabolism , Complement Factor B/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Glioblastoma/blood , Glioblastoma/immunology , Glioblastoma/physiopathology , Humans , Male , Mannose-Binding Lectin/metabolism , Middle Aged , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...